Cargando…
The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial
BACKGROUND: Sepsis is an important cause of neonatal death and perinatal brain damage, particularly in preterm infants. While effective antibiotic treatment is essential treatment for sepsis, resistance to antibiotics is increasing. Adjuvant therapies, such as intravenous immunoglobulin, therefore o...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626572/ https://www.ncbi.nlm.nih.gov/pubmed/19063731 http://dx.doi.org/10.1186/1471-2393-8-52 |
Ejemplares similares
-
Intravenous Immunoglobulin Doesn’t Decrease Mortality for Suspected or Proven Sepsis in the Neonate
por: AlOmran, Abbas
Publicado: (2013) -
Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis
por: Serafettin Tekgunduz, Kadir, et al.
Publicado: (2015) -
Effects of immunotherapy on mortality in neonates with suspected or proven sepsis: a systematic review and network meta-analysis
por: Li, Yuhang, et al.
Publicado: (2019) -
Role of immunoglobulins in neonatal sepsis
por: Capasso, L, et al.
Publicado: (2014) -
Antimicrobial resistance in neonates with suspected sepsis
por: Yadav, S. K., et al.
Publicado: (2021)